Premium
P4‐033: ABCA1 ACTIVATION BY CS6253 AS A THERAPEUTIC FOR APOE4 ‐ASSOCIATED ALZHEIMER'S DISEASE
Author(s) -
Johansson Jan O.,
Yassine Hussein N.,
Liraz Ori,
Zetterberg Henrik,
Valencia - Olvera Ana,
Ladu Mary Jo,
Michaelson Daniel M.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.3692
Subject(s) - abca1 , apolipoprotein e , endocrinology , medicine , biology , pathogenesis , context (archaeology) , ex vivo , agonist , in vivo , cholesterol , microbiology and biotechnology , disease , receptor , biochemistry , transporter , genetics , gene , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom